JOURNAL OF IQRO – ЖУРНАЛ ИҚРО – IQRO JURNALI – volume 15, issue 02, 2025
ISSN: 2181-4341, IMPACT FACTOR ( RESEARCH BIB ) – 7,245, SJIF – 5,431
ILMIY METODIK JURNAL
Mohd Sajid Arshad
Assistant, Department of Physiology, FMIOPH, Fergana, Uzbekistan
Musthaq Ahmed Mohamed
Professor, Department of microbiology, virology and Immunology, FMIOPH, Fergana,
Uzbekistan
THE ROLE OF MICROBIOMES IN SHAPING HOST IMMUNITY AND
INFLAMMATORY RESPONSES
Abstract:
The human microbiome, encompassing the gut, skin, and oral ecosystems, plays a
fundamental role in regulating host immunity and modulating inflammatory responses. These
microbial communities influence immune system development, barrier integrity, and cytokine
production, contributing to both local and systemic immune homeostasis. The gut microbiome,
through the production of short-chain fatty acids, enhances intestinal barrier function and
promotes regulatory T cell expansion. The skin and oral microbiomes provide antimicrobial
defense and regulate inflammation at epithelial interfaces. Dysbiosis in any of these microbiomes
is linked to a variety of inflammatory, autoimmune, and chronic diseases, including
inflammatory bowel disease, atopic dermatitis, and cardiovascular conditions. The gut-skin and
gut-oral axes further illustrate the interconnectedness of these ecosystems. Therapeutic
interventions such as probiotics, prebiotics, fecal microbiota transplantation, and dietary
modifications offer promising strategies to restore microbial balance and ameliorate immune-
related pathologies. Understanding the interplay between microbiomes and the immune system
holds significant potential for novel treatments targeting immune and inflammatory disorders.
Keywords:
microbiome, immunity, inflammation, dysbiosis, probiotics
Introduction
The human microbiome, encompassing the gut, skin, and oral microbiomes, plays a pivotal role
in shaping host immunity and inflammatory responses. The gut microbiome, in particular, is a
critical player in immune system regulation, influencing the maturation of immune cells and the
production of signaling molecules that can be either pro- or anti-inflammatory[1–3]. It is
involved in the development of immune responses, including the induction of immunoglobulin A
(IgA) and the regulation of CD4+ T cells, which are crucial for maintaining immune
homeostasis[3,4]. Dysbiosis, or the imbalance of the gut microbiota, has been linked to a range
of inflammatory and autoimmune diseases, such as inflammatory bowel disease, rheumatoid
arthritis, and multiple sclerosis[4–6]. The skin microbiome also contributes to immune regulation
by protecting against pathogens and modulating inflammatory responses, with dysbiosis
associated with conditions like atopic dermatitis and psoriasis[1,2,7]. Similarly, the oral
microbiome plays a role in maintaining oral health and preventing inflammatory dental
diseases[1]. The interconnectedness of these microbiomes is evident in the skin-gut axis, where
gut microbiome alterations can influence skin conditions, highlighting the systemic nature of
microbiome interactions[7]. Therapeutic strategies, such as probiotics and prebiotics, aim to
restore microbiome balance and have shown promise in treating various disorders by modulating
immune responses[1,4,8]. Overall, the microbiome's influence on immunity and inflammation
underscores its potential as a target for novel therapeutic interventions to enhance human
health[1,5,9].
Gut Microbiome and Immunity
JOURNAL OF IQRO – ЖУРНАЛ ИҚРО – IQRO JURNALI – volume 15, issue 02, 2025
ISSN: 2181-4341, IMPACT FACTOR ( RESEARCH BIB ) – 7,245, SJIF – 5,431
ILMIY METODIK JURNAL
The gut microbiome is the most densely populated microbial ecosystem in the human div, with
a profound influence on immune system development and function. It is composed of diverse
microbial species that interact with the host through multiple mechanisms:
1. Immune System Development: The gut microbiome is essential for the maturation of the
immune system. It stimulates the development of gut-associated lymphoid tissues (GALT) and
regulates the balance between pro-inflammatory and anti-inflammatory responses [6] [8].
2. Barrier Function: The gut microbiome produces metabolites such as short-chain fatty acids
(SCFAs), which strengthen the intestinal barrier and prevent the translocation of harmful
pathogens [9] [13].
3. Modulation of Inflammatory Responses: SCFAs, derived from microbial fermentation of
dietary fibers, inhibit the production of pro-inflammatory cytokines and promote the expansion
of regulatory T cells (Tregs), which suppress excessive inflammation [6] [8] [13].
4. Dysbiosis and Disease: Dysbiosis, or an imbalance in the gut microbiome, has been
implicated in various inflammatory and autoimmune diseases, including inflammatory bowel
disease (IBD), rheumatoid arthritis, and obesity [3] [11] [17].
Table: Comparison of Gut, Skin, and Oral Microbiomes in Immunity and Inflammation
Microbiome Key Role in Immunity
Associated Diseases
Citation
Gut
Produces SCFAs, regulates Tregs,
maintains barrier function
IBD, obesity, autoimmune
diseases
[6] [8] [13]
Skin
Produces antimicrobial peptides,
regulates inflammation
Atopic dermatitis, psoriasis
[2] [20]
Oral
Promotes IgA production, surveils
pathogens
Periodontal
disease,
cardiovascular disease
[2] [3]
Skin Microbiome and Immunity
The skin microbiome serves as the first line of defense against external pathogens and plays a
critical role in maintaining immune homeostasis:
1. Barrier Function: The skin microbiome produces antimicrobial peptides and acids that
inhibit the colonization of pathogenic microorganisms [2] [4].
2. Immune Regulation: The skin microbiome modulates the innate and adaptive immune
responses. For example, commensal bacteria such as
Staphylococcus epidermidis
produce
metabolites that suppress inflammation and promote wound healing [4] [20].
3. Dysbiosis and Skin Disorders: Dysbiosis of the skin microbiome has been linked to chronic
inflammatory conditions such as atopic dermatitis (AD), psoriasis, and acne. In AD, the reduced
diversity of the skin microbiome and the overgrowth of
Staphylococcus aureus
exacerbate
inflammation and impair the skin barrier [20].
4. Therapeutic Interventions: Probiotics and prebiotics have shown promise in restoring the
balance of the skin microbiome and alleviating inflammatory skin conditions [2] [20].
Oral Microbiome and Immunity
JOURNAL OF IQRO – ЖУРНАЛ ИҚРО – IQRO JURNALI – volume 15, issue 02, 2025
ISSN: 2181-4341, IMPACT FACTOR ( RESEARCH BIB ) – 7,245, SJIF – 5,431
ILMIY METODIK JURNAL
The oral microbiome is a complex ecosystem that influences both local and systemic immunity:
1. Immune Surveillance: The oral microbiome interacts with immune cells in the oral mucosa,
promoting the production of IgA antibodies and maintaining tolerance to commensal bacteria
while mounting responses to pathogens [2] [3].
2. Inflammation and Disease: Dysbiosis of the oral microbiome has been associated with
periodontal disease, which is characterized by chronic inflammation and tissue destruction. This
inflammation can also contribute to systemic conditions such as cardiovascular disease and
diabetes [3] [11].
3. Modulation of Systemic Inflammation: The oral microbiome influences systemic
inflammation through the release of metabolites and bacterial components, such as
lipopolysaccharides, which can affect distant organs via the bloodstream [3] [13].
4. Therapeutic Strategies: Targeting the oral microbiome through probiotics and dietary
interventions has shown potential in reducing inflammation and improving oral and systemic
health [2] [6].
Interplay Between Microbiomes and Host Immunity
The gut, skin, and oral microbiomes do not function in isolation but interact through complex
mechanisms to shape host immunity:
1. Gut-Skin Axis: The gut microbiome influences the skin microbiome through the production
of metabolites that regulate inflammation and barrier function. For example, SCFAs produced in
the gut can modulate the immune response in the skin [20].
2. Gut-Oral Axis: The gut and oral microbiomes share microbial species, and dysbiosis in one
ecosystem can influence the other. For instance, an imbalance in the gut microbiome has been
linked to oral infections and inflammation [3] [11].
3. Systemic Inflammation: Dysbiosis in any of these microbiomes can lead to systemic
inflammation, which contributes to chronic diseases such as cardiovascular disease, diabetes, and
autoimmune disorders [3] [9] [13].
Therapeutic Strategies to Modulate Microbiomes
Targeting the gut, skin, and oral microbiomes offers promising therapeutic avenues for immune-
mediated and inflammatory diseases:
1. Probiotics and Prebiotics: Probiotics (live beneficial microorganisms) and prebiotics (non-
digestible fibers that promote microbial growth) have been used to restore microbial balance and
reduce inflammation [2] [6] [20].
2. Fecal Microbiota Transplantation (FMT): FMT has shown efficacy in treating conditions
like
Clostridioides difficile
infections and inflammatory bowel disease by restoring gut
microbiota diversity [6] [14].
3. Dietary Interventions: Diet plays a critical role in shaping microbiome composition. A diet
rich in fibers, polyphenols, and omega-3 fatty acids can promote a balanced microbiome and
reduce inflammation [6] [18].
4. Topical Therapies: For skin conditions, topical probiotics and antimicrobial peptides have
been explored as therapeutic options to restore the skin microbiome and reduce
inflammation [20].
Conclusion
JOURNAL OF IQRO – ЖУРНАЛ ИҚРО – IQRO JURNALI – volume 15, issue 02, 2025
ISSN: 2181-4341, IMPACT FACTOR ( RESEARCH BIB ) – 7,245, SJIF – 5,431
ILMIY METODIK JURNAL
The gut, skin, and oral microbiomes are integral to human immune homeostasis and
inflammatory regulation. Dysbiosis in these ecosystems has been implicated in a wide range of
diseases, from autoimmune disorders to chronic inflammatory conditions. Understanding the
complex interactions between these microbiomes and the host immune system is crucial for
developing novel therapeutic strategies to restore microbial balance and improve human health.
References:
1. Aqsa Athar et al. The human microbiome: A critical player in health and disease // World
journal of biology and biotechnology. 2023.
2. Karabaev Jasurbek Mavlyanjanovich. (2025). CURRENT CHALLENGES AND
ADVANCES IN PEDIATRIC TRAUMATOLOGY.
International Multidisciplinary Journal for
Research
&
Development
,
12
(05),
157–160.
Retrieved
from
https://www.ijmrd.in/index.php/imjrd/article/view/3051
3. Emily A. Mann et al. The Gut Microbiome: Human Health and Inflammatory Skin Diseases
// Annals of Dermatology. 2020. Vol. 32, № 4. P. 265–272.
4. To Lee. Gut Microbiota and Immune Responses // Science insights. 2022. Vol. 40, № 3. P.
443–449.
5. Talia Attiq et al. Role of Gut Microbiota in Immune System Regulation // Pakistan journal
of health sciences. 2024. P. 02–12.
6. Verónica I. Dodero, Servaas A. Morré, Payam Behzadi. Editorial: Gut microbiota and
immunity in health and disease: dysbiosis and eubiosis’s effects on the human div // Frontiers
in Immunology. 2024. Vol. 15.
7. Miriãn Ferrão Maciel-Fiuza et al. Role of gut microbiota in infectious and inflammatory
diseases // Frontiers in Microbiology. 2023. Vol. 14. P. 1098386–1098386.
8. Beata Polkowska-Pruszyńska, Agnieszka Gerkowicz, Dorota Krasowska. The gut
microbiome alterations in allergic and inflammatory skin diseases – an update // Journal of The
European Academy of Dermatology and Venereology. 2020. Vol. 34, № 3. P. 455–464.
9. Sarah Ashman, Hari Krishnan Krishnamurthy. The Gut Microbiome. 2019. P. 61–98.
10. Padmaja Phani et al. Role of Gut Microbiome Composition in Shaping Host Immune
System Development and Health. 2023. P. 39–65.
11. Meliboev, R. A., & Eminov, R. I. (2025). EXPLORING METHODS TO IMPROVE THE
TREATMENT
OF
COMPLICATIONS
ARISING
FROM
ENDOUROLOGICAL
OPERATIONS FOR URINARY STONE DISEASE (LITERATURE REVIEW).
mortality
,
4
, 13.
12. Qoraboyev Jasurbek Mavlonjon O‘G‘Li, & Raximova Ruxshona Shavkat Qizi (2024).
KATTALARDAGI OG‘IR MIYA SHIKASTLANISHI. Eurasian Journal of Medical and
Natural Sciences, 4 (2), 156-162. doi: 10.5281/zenodo.10776140
13. Tashmamatova, D. K. (2025). UNDERSTANDING AND MANAGING CONSTIPATION
IN
CHILDREN
AGED
0-3:
CAUSES,
DIAGNOSIS,
AND
TREATMENT
STRATEGIES.
ORIENTAL JOURNAL OF MEDICINE AND NATURAL SCIENCES
,
2
(1), 4-12.
14. Ёкубов, Д., & Мазалова, А. (2024). On differential diagnostics of spinal cord pathology of
organic and functional genesis.
Актуальные вопросы фундаментальной медицины: сегодня и
в будущем
,
1
(1), 36-36.
15. Кoрабоев,
Ж.
(2024).
ПАТОЛОГИЧЕСКИЕ
ПЕРЕЛОМЫ
КОСТЕЙ.
В
МЕЖДУНАРОДНАЯ КОНФЕРЕНЦИЯ АКАДЕМИЧЕСКИХ НАУК (Т. 3, Выпуск 7, сс.
32–35). Zenodo. https://doi.org/10.5281/zenodo.11632660
